Last modified
April 29, 2010


 

NEW!
BioProtein Technologies creates TRM (Transgenic Rabbit Models)
a subsidiary company specialized in the development and production of transgenic rabbit animal models

--> More...




PRESS RELEASE
BioProtein strengthens its capital base
and expands its commercial offer
--> More...



 :: MANUFACTURING SERVICES ::



BioProtein Technologies is a Contract Manufacturing Organization specializing in the production of human therapeutic proteins & vaccines in the milk of transgenic rabbits.

BioProtein Technologies' unique manufacturing capabilities are designed to provide pharmaceutical and biotechnology companies, as well as academic and research organizations, with the highest standard in recombinant protein & vaccine production.

 

RECOMBINANT PROTEIN PRODUCTION
RECOMBINANT VACCINE PRODUCTION
- Monoclonal Antibodies
- Plasma Proteins
- Hormones
- Peptides
- Vaccines based on vaccinating proteins
- Multivalent VLP-based Vaccines
--> More…

The Company’s proprietary technology platform allows it to provide customers with gram to kilogram quantities of highly purified biopharmaceuticals within competitive time-frame.
--> More…

:: EXPERTISE ::  
BioProtein Technologies has privileged access to the expertise and know-how developed by INRA (French Agronomy Research Institute) for the production of recombinant proteins and vaccines in the milk of transgenic rabbits.
--> More...
:: CREATION OF TRM ::

BioProtein Technologies creates TRM (Transgenic Rabbit Models), a subsidiary company dedicated to the development and production of transgenic rabbits to be used as animal models for the study of human diseases.
--> More...


 :: MAILING ADDRESS::

BioProtein Technologies - Domaine de Vilvert, Bâtiment 220
78350 Jouy-en-Josas
Ph: +33 (0)1 39 24 80 80  Fax:+33 (0)1 39 24 80 89  contact@bioprotein.com

Headquarters : Chez SLGP – 5 place Bellecour – 69002 LYON